Intriguingly, no significant difference was observed for the tumor proliferation markers MKi67, MCM2, and MCM6, suggesting that recurrence is driven primarily by TME remodeling and the ensuing changes in the crosstalk between the tumor and TME, rather than by an increased proliferation potential of the tumor cells. The gene discussed is MCM6; the disease is neoplasm.